Use of anti-viral therapies in hospitalised COVID-19 patients in the United Arab Emirates: a cost-effectiveness and health-care resource use analysis.
Saved in:
| Title: | Use of anti-viral therapies in hospitalised COVID-19 patients in the United Arab Emirates: a cost-effectiveness and health-care resource use analysis. |
|---|---|
| Authors: | Subhi A; Al-Qassimi Hospital Sharjah, Sharjah, United Arab Emirates., Shamy AME; Ministry of Health and Prevention, Dubai, United Arab Emirates., Hussein SAM; Global Medical Solution, Abu Dhabi, United Arab Emirates., Jarrett J; Gilead Sciences Inc, London, UK. james.jarrett@gilead.com., Kozma S; Gilead Sciences Inc, Dubai, United Arab Emirates., Harfouche C; Gilead Sciences Inc, Dubai, United Arab Emirates., Al Dallal S; Emirates Health Economics Society, Dubai, United Arab Emirates. |
| Source: | BMC health services research [BMC Health Serv Res] 2023 Apr 20; Vol. 23 (1), pp. 383. Date of Electronic Publication: 2023 Apr 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
